본문 바로가기
KERD
논문KCI 등재

Sarcopenia Associated with Chronic Obstructive Pulmonary Disease

김기욱|신명준|신용범|김상훈
대한골대사학회 (The Korean Society of Bone Metabolism)|2019.05|대한골대사학회지 (Journal of Bone Metabolism)|제26권 제2호|pp. 65-74

2

조회

0

다운로드

6

인용

0

참고문헌

키워드

RehabilitationVitamin DSarcopeniaExercise therapyPulmonary diseaseChronic obstructive
주제분류정형외과학

초록

Sarcopenia is frequently associated with chronic diseases such as chronic obstructive pulmonary disease (COPD) and cancer. COPD, which is characterized by an irreversible airflow limitation, exacerbates respiratory distress as the disease progresses. The prevalence of sarcopenia in stable COPD was reported to be 15% to 25% in previous foreign studies and 25% in a Korean study. As the amount of activity decreases, muscle mass decreases and eventually oxygen cannot be used effectively, resulting in a vicious cycle of deterioration of exercise capacity. Deconditioning due to decreased activity is a major cause of limb muscle dysfunction in patients with COPD. In these patients, the factors that decrease muscle strength and endurance include chronic inflammation, oxidative stress, inactivity, hypoxemia, hormone abnormality, deficits of nutrients such as protein and vitamin D, and the use of systemic corticosteroid. Therefore, treatment and management should either inhibit this process or should be directed toward supplementing the deficiency, such as with exercise, nutritional support, and medications and supplements. The relationship between sarcopenia and COPD is increasingly being reported, with some overlap in clinical features and treatments. We are fascinated to be able to diagnose 2 diseases through similar physical performance tests and to improve both diseases using the same treatment such as exercise. Therefore, this review summarizes the clinical relevance and integrative management of the 2 diseases.

Abstract

Sarcopenia is frequently associated with chronic diseases such as chronic obstructive pulmonary disease (COPD) and cancer. COPD, which is characterized by an irreversible airflow limitation, exacerbates respiratory distress as the disease progresses. The prevalence of sarcopenia in stable COPD was reported to be 15% to 25% in previous foreign studies and 25% in a Korean study. As the amount of activity decreases, muscle mass decreases and eventually oxygen cannot be used effectively, resulting in a vicious cycle of deterioration of exercise capacity. Deconditioning due to decreased activity is a major cause of limb muscle dysfunction in patients with COPD. In these patients, the factors that decrease muscle strength and endurance include chronic inflammation, oxidative stress, inactivity, hypoxemia, hormone abnormality, deficits of nutrients such as protein and vitamin D, and the use of systemic corticosteroid. Therefore, treatment and management should either inhibit this process or should be directed toward supplementing the deficiency, such as with exercise, nutritional support, and medications and supplements. The relationship between sarcopenia and COPD is increasingly being reported, with some overlap in clinical features and treatments. We are fascinated to be able to diagnose 2 diseases through similar physical performance tests and to improve both diseases using the same treatment such as exercise. Therefore, this review summarizes the clinical relevance and integrative management of the 2 diseases.

참고문헌 (63)

  1. Cruz-Jentoft AJ, "Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People", Age Ageing, 39, pp.412~423 (2010)
  2. Rosenberg IH, "Sarcopenia: origins and clinical relevance", J Nutr, 127, pp.990s~991s (1997)
  3. Roubenoff R, "Sarcopenia: effects on body composition and function", J Gerontol A Biol Sci Med Sci, 58, pp.1012~1017 (2003)
  4. Fielding RA, "Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia", J Am Med Dir Assoc, 12, pp.249~256 (2011)
  5. 권형준, "Prevalence of Sarcopenia in the Korean Woman Based on the Korean National Health and Nutritional Examination Surveys", 대한골대사학회지, 23(1), pp.23~26 (2016), 대한골대사학회[DOI]
  6. 김경민, "Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia", The Korean Journal of Internal Medicine, 31(4), pp.643~650 (2016), 대한내과학회[DOI]
  7. Yoo KH, "Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008", Respirology, 16, pp.659~665 (2011)
  8. Cruz-Jentoft AJ, "Sarcopenia: revised European consensus on definition and diagnosis", Age Ageing, 48, pp.16~31 (2019)
  9. Studenski SA, "The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates", J Gerontol A Biol Sci Med Sci, 69, pp.547~558 (2014)
  10. Visser M, "Consequences of sarcopenia", Clin Geriatr Med, 27, pp.387~399 (2011)
  11. 최경묵, "Sarcopenia and Sarcopenic Obesity", Endocrinology and Metabolism, 28(2), pp.86~89 (2013), 대한내분비학회
  12. Roubenoff R, "Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study", Am J Med, 115, pp.429~435 (2003)
  13. Lim S, "Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA).", Diabetes Care, 33, pp.1652~1654 (2010)
  14. "Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and mortality" (2013)[URL]
  15. Spruit MA, "An official American Thoracic Society", European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation, 2013, pp.188, e13~e64
  16. Garvey C, "Pulmonary rehabilitation exercise prescription in chronic obstructive lung disease: US survey and review of guidelines and clinical practices", J Cardiopulm Rehabil Prev, 33, pp.314~322 (2013)
  17. Celli BR, "The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease", N Engl J Med, 350, pp.1005~1012 (2004)
  18. Maltais F, "An official American Thoracic Society", European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease, 2014, pp.189, e15~e62
  19. Vestbo J, "Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study", Am J Respir Crit Care Med, 173, pp.79~83 (2006)
  20. Coronell C, "COPD and body weight in a Mediterranean population", Clin Nutr, 21, pp.437~ (2002)
  21. Schols AM, "Body composition and mortality in chronic obstructive pulmonary disease", Am J Clin Nutr, 82, pp.53~59 (2005)
  22. Bernard S, "Peripheral muscle weakness in patients with chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 158, pp.629~634 (1998)
  23. Gosker HR, "Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease", Eur Respir J, 19, pp.617~625 (2002)
  24. Richardson RS, "Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 159, pp.881~885 (1999)
  25. Koechlin C, "Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?", Am J Respir Crit Care Med, 169, pp.1022~1027 (2004)
  26. Koechlin C, "Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease", Thorax, 60, pp.834~841 (2005)
  27. Couillard A, "Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 167, pp.1664~1669 (2003)
  28. Allaire J, "Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD", Thorax, 59, pp.673~678 (2004)
  29. Mador MJ, "Quadriceps fatigue after cycle exercise in patients with COPD compared with healthy control subjects", Chest, 123, pp.1104~1111 (2003)
  30. Saey D, "Assessment of muscle fatigue during exercise in chronic obstructive pulmonary disease", Muscle Nerve, 34, pp.62~71 (2006)
  31. Gan WQ, "Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis", Thorax, 59, pp.574~580 (2004)
  32. Byun MK, "Sarcopenia correlates with systemic inflammation in COPD", Int J Chron Obstruct Pulmon Dis, 12, pp.669~675 (2017)
  33. Spruit MA, "Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I", Thorax, 58, pp.752~756 (2003)
  34. Marquis K, "Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 166, pp.809~813 (2002)
  35. Wagner PD, "Possible mechanisms underlying the development of cachexia in COPD", Eur Respir J, 31, pp.492~501 (2008)
  36. Jones SE, "Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation", Thorax, 70, pp.213~218 (2015)
  37. Hak Chul Jang, "How to Diagnose Sarcopenia in Korean Older Adults?", Annals of geriatric medicine and research, 22(2), pp.73~79 (2018), 대한노인병학회[DOI]
  38. Limpawattana P, "Frailty syndrome in ambulatory patients with COPD", Int J Chron Obstruct Pulmon Dis, 12, pp.1193~1198 (2017)
  39. Vogelmeier CF, "Global Strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary", Am J Respir Crit Care Med, 195, pp.557~582 (2017)
  40. Suetta C, "Effect of strength training on muscle function in elderly hospitalized patients", Scand J Med Sci Sports, 17, pp.464~472 (2007)
  41. Levinger I, "The reliability of the 1RM strength test for untrained middle-aged individuals", J Sci Med Sport, 12, pp.310~316 (2009)
  42. Binder EF, "Effects of progressive resistance training on body composition in frail older adults: results of a randomized, controlled trial", J Gerontol A Biol Sci Med Sci, 60, pp.1425~1431 (2005)
  43. Orr R, "Efficacy of progressive resistance training on balance performance in older adults: a systematic review of randomized controlled trials", Sports Med, 38, pp.317~343 (2008)
  44. Low DC, "Effectiveness of exercise interventions to improve postural control in older adults: a systematic review and meta-analyses of centre of pressure measurements", Sports Med, 47, pp.101~112
  45. American College of Sports Medicine, "ACSM’s guidelines for exercise testing and prescription" (2018), Wolters Kluwer
  46. Kendrick KR, "Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma", J Emerg Nurs, 26, pp.216~222 (2000)
  47. Ries AL, "Pulmonary rehabilitation: Joint ACCP", AACVPR evidence-based clinical practice guidelines, 2007, pp.131, 4s~42s
  48. van Gestel AJ, "Prevalence and prediction of exercise-induced oxygen desaturation in patients with chronic obstructive pulmonary disease", Respiration, 84, pp.353~359 (2012)
  49. Johannson KA, "Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure", Eur Respir J, 43, pp.1124~1131 (2014)
  50. Ministry of Health and Welfare, The Korean Nutrition Society, "Dietary reference intakes for Koreans 2015" (2015), Ministry of Health and Welfare, The Korean Nutrition Society
  51. Houston DK, "Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) Study", Am J Clin Nutr, 87, pp.150~155 (2008)
  52. Bauer JM, "Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial", J Am Med Dir Assoc, 16, pp.740~747 (2015)
  53. Verreijen AM, "A high whey protein-, leucine-, and vitamin D-enriched supplement preserves muscle mass during intentional weight loss in obese older adults: a double-blind randomized controlled trial", Am J Clin Nutr, 101, pp.279~286 (2015)
  54. Tieland M, "Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial", J Am Med Dir Assoc, 13, pp.713~719 (2012)
  55. Ferreira IM, "Nutritional supplementation for stable chronic obstructive pulmonary disease", Cochrane Database Syst Rev, 12, pp.Cd000998~ (2012)
  56. Bauer J, "Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group", J Am Med Dir Assoc, 14, pp.542~559 (2013)
  57. Boland R, "Role of vitamin D in skeletal muscle function", Endocr Rev, 7, pp.434~448 (1986)
  58. Kuchuk NO, "Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons", J Clin Endocrinol Metab, 94, pp.1244~1250 (2009)
  59. Wilson GJ, "Effects of beta-hydroxy-beta-methylbutyrate (HMB) on exercise performance and body composition across varying levels of age, sex, and training experience: A review", Nutr Metab (Lond), 5, pp.1~ (2008)
  60. Wu H, "Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults: a systematic review and meta-analysis", Arch Gerontol Geriatr, 61, pp.168~175 (2015)
  61. Molfino A, "Beta-hydroxy-beta-methylbutyrate supplementation in health and disease: a systematic review of randomized trials", Amino Acids, 45, pp.1273~1292 (2013)
  62. Dalton JT, "Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer", Curr Opin Support Palliat Care, 7, pp.345~351 (2013)
  63. Kolosova NG, "Metformin reduces the signs of sarcopenia in old OXYS rats", Adv Gerontol, 6, pp.70~74 (2016)

관련 논문AI추천

만성폐쇄성폐질환 환자의 영양관리이관호영남대학교 의과대학 · Journal of Yeungnam Medical Science2004 · 제21권 제2호Review of Epidemiology, Diagnosis, and Treatment of Osteosarcopenia in Korea유준일, 하용찬대한골대사학회 · 대한골대사학회지2018 · 제25권 제1호Relationship between Chronic Obstructive Pulmonary Disease Severity and Surface Electromyography Parameters during Fatigue Caused by Knee Extensor Contractions신명준, Jang Myung Hun, Kim Sang Hun, Lee Jun Woo, Shin Ho Jeong대한근전도전기진단의학회 · 대한근전도 전기진단의학회지2023 · 제25권 제2호Sarcopenia: Definition, Epidemiology, and Pathophysiology김태년, 최경묵대한골대사학회 · 대한골대사학회지2013 · 제20권 제1호Osteoporosis Associated with Chronic Obstructive Pulmonary DiseaseDaisuke Inoue, Reiko Watanabe, Ryo Okazaki대한골대사학회 · 대한골대사학회지2016 · 제23권 제3호Prevalence of Osteoporosis in Korean Patients with Chronic Obstructive Pulmonary Disease and Their Health-related Quality of Life According to the Korea National Health and Nutrition Examination Survey 2008-2011권혜영, 이상희대한골대사학회 · 대한골대사학회지2017 · 제24권 제4호

이 간행물의 다른 논문 (7건)

Impact of Artistic Gymnastics on Bone Formation Marker, Density and Geometry in Female Adolescents: ABCD-Growth StudyEduardo D.L. Mesquita, Han C.G. Kemper, Rômulo Araújo Fernandes, Rafael Luiz-de-Marco, Isabella Neto Exupério, Ricardo Ribeiro Agostinete, André Oliveira Werneck, Santiago Maillane-Vanegaspp. 75-82Disability Weights for Osteoporosis and Osteoporotic Fractures in South Korea박지혜, 안종륜, 배그린, 권혜영, 양효원, 김유진pp. 83-88Preventive Effects of Low Parathyroid Hormone Levels on Hip Fracture in Patients with Vitamin D Deficiency류근정, 이순철, 고정민, 김철호, 김형경, 김지완, 장재석, 하용찬, 변성은, 하청수pp. 89-95Incidence and Mortality of Osteoporotic Fracture in Rheumatoid Arthritis in South Korea Using Nationwide Claims Data김현호, 권혜영, 하용찬, 성윤경pp. 97-104Incidence of Osteoporotic Refractures Following Proximal Humerus Fractures in Adults Aged 50 Years and Older in Korea장선미, 김하영, 이영균, 유준일, 하용찬, 노재휘, 정형석, 박상민pp. 105-111
원문 보기